Eczema News Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September – The Globe and Mail eczemarelief October 5, 2025 Share Here’s Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September The Globe and Mail Source link